Core Viewpoint - Heng Rui Medicine (01276) announced a share repurchase plan, indicating a strategic move to enhance shareholder value through stock buybacks [1] Summary by Relevant Sections Share Repurchase Details - In November 2025, the company repurchased 979,900 shares through the Shanghai Stock Exchange, representing 0.015% of the total share capital, with a maximum purchase price of RMB 63.28 per share and a minimum of RMB 59.32 per share, totaling RMB 59.7885 million (excluding transaction fees) [1] - As of November 21, 2025, the cumulative shares repurchased amounted to 8,898,700, accounting for 0.13% of the total share capital, with a maximum price of RMB 70.00 per share and a minimum of RMB 59.32 per share, totaling RMB 595 million (excluding transaction fees) [1]